A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery (Q45166388)

10 December 2017

title

A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery (English)

1 reference

10 December 2017

main subject

hepatocellular carcinoma

1 reference

1 reference

Wei-Yu Kao

1

1 reference

10 December 2017

Chien-Wei Su

2

1 reference

10 December 2017

Gar-Yang Chau

3

1 reference

10 December 2017

Wing-Yiu Lui

4

1 reference

10 December 2017

Chew-Wun Wu

5

1 reference

10 December 2017

Jaw-Ching Wu

6

1 reference

10 December 2017

publication date

1 April 2011

1 reference

10 December 2017

published in

World Journal of Surgery

1 reference

10 December 2017

volume

35

1 reference

10 December 2017

issue

4

1 reference

10 December 2017

page(s)

858-867

1 reference

Novel advancements in the management of hepatocellular carcinoma in 2008.

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Diagnosis and Treatment of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Etiology-dependent molecular mechanisms in human hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Viral hepatocarcinogenesis: from infection to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Hepatitis C virus-induced hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Hepatocellular Carcinoma (HCC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-010-0928-Z

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21207029

12 December 2020

inferred from PubMed ID database lookup

Differences in long-term outcome and prognostic factors according to viral status in patients with hepatocellular carcinoma treated by surgery

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21207029

12 December 2020

inferred from PubMed ID database lookup

Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21207029

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00268-010-0928-Z

1 reference

Dimensions Publication ID

10 December 2017

1004892393

0 references

Fatcat ID

release_rlveycp2rndztiz7jbkqhyhrae

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rlveycp2rndztiz7jbkqhyhrae

24 November 2022

mapped directly with Wikidata item

1 reference